Skip to main content
logo
Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
10.04
-0.19 (-1.86%)
At close: Aug 21, 2026, 4:00 PM EDT
10.20
+0.16 (1.59%)
After-hours: Aug 21, 2026, 7:37 PM EDT

Cartesian Therapeutics Revenue

Cartesian Therapeutics had revenue of $1.48M in the twelve months ending June 30, 2026, up 43.96% year-over-year. In the year 2025, Cartesian Therapeutics had annual revenue of $2.80M, down -92.81%.

Revenue (ttm)
$1.48M
Revenue Growth
+43.96%
P/S Ratio
205.66
Revenue / Employee
$19,693
Employees
75
Market Cap
303.76M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.80M-36.12M-92.81%
Dec 31, 202438.91M12.91M49.64%
Dec 31, 202326.00M-84.77M-76.53%
Dec 31, 2022110.78M25.70M30.21%
Dec 31, 202185.08M68.48M412.60%
Dec 31, 202016.60M9.92M148.57%
Dec 31, 20196.68M5.77M639.42%
Dec 31, 2018903.00K696.00K336.23%
Dec 31, 2017207.00K-7.88M-97.44%
Dec 31, 20168.08M2.07M34.47%
Dec 31, 20156.01M2.97M97.73%
Dec 31, 20143.04M1.56M105.54%
Dec 31, 20131.48M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Vanda Pharmaceuticals215.72M
Bicycle Therapeutics61.21M
Orchestra BioMed Holdings31.98M
ProQR Therapeutics21.05M
Fate Therapeutics6.49M
YD Bio510.36K
Vicore Pharma Holding AB412.09K
SAB Biotherapeutics114.70K
Revenue Rankings

RNAC News

More News